Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Healthcare services beat-and-raise candidate: Q1 2026 revenue and adjusted EPS beat estimates, full-year guidance was raised, VITAS growth remained strong with admissions up 6.9%, and the company added a new $300M buyback authorization.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Robust cash generation ⢠Higher debt load ⢠Weaker liquidity CHE remains highly profitable with strong cash flow and interest coverage, but rising leverage, weakening liquidity, and richer valuation warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Lower highs ⢠Critical support ⢠Weak momentum Support Level: $500â505 (secondary: $490â492) Resistance Level: $514â520 CHE remains in a short-term downtrend, with $500â505 support critical; a break below $500 risks $490â492, while a move above $514â520 would ease bearish pressure.
Sentiment & News
Key News Insights: ⢠Institutional Accumulation ⢠Roto-Rooter Expansion ⢠Legal Scrutiny Institutional buying and Roto-Rooter's $60.6M acquisition support Chemed's growth outlook, though insider selling and fiduciary-duty scrutiny present risks.
AI Summary
CHE is now principally a VITAS-driven healthcare growth story: strong census, margin expansion, and reduced Medicare-cap risk can support earnings, but investors should remain cautious until Roto-Rooter proves its Google-driven customer-acquisition costs are temporary rather than a structural margin resetâespecially at an elevated valuation and with weaker liquidity.
Description
Chemed Corporation delivers hospice and palliative care through a multidisciplinary network of clinicians, aides, social workers, clergy and volunteers across the United States under its VITAS segment, and provides plumbing, drain, excavation and water-restoration services to residential and commercial customers via company branches, independent contractors and franchisees under its Roto-Rooter segment. The company operates these two distinct businesses from its headquarters in Cincinnati and has been incorporated since 1970.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Apr 28 | May 5 | CHE | Chemed Corporation | Healthcare services beat-and-raise candidate: Q1 2026 revenue and adjusted EPS beat estimates, full-year guidance was raised, VITAS growth remained strong with admissions up 6.9%, and the company added a new $300M buyback authorization. | Closed | +1.5% |